National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05DA	EXTRANEAL (ICODEXTRIN 7.5%) SINGLE BAG	B	Sodium lactate - 4.5g/l, Magnesium Chloride - 0.051g/l, Calcium chloride - 0.257g/l, Sodium chloride - 5.4g/l, Icodextrin - 75.0 g/l		Injectable solution	1,998,025 L.L
C05CX	TANAKAN	B	Ginkgo biloba - 40mg	40mg	Tablet, film coated	1,662,333 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	1,032,071 L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 120mcg	120mcg	Tablet, Oral lyophilisate	4,970,873 L.L
L04AX02	THALIDOMIDE BMS	B	Thalidomide - 50mg	50mg	Capsule	27,387,764 L.L
N03AB02	EPANUTIN	B	Phenytoin sodium - 100mg	100mg	Capsule	739,113 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L
R05CB01	FLUIMUCIL MUCOLYTIC	B	N-acetylcysteine - 2%	2%	Syrup	595,322 L.L
S02D	CERULYSE	B	Xylene - 5g/100g	5g/100g	Drops solution	339,992 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Enema	2,791,161 L.L
A11AB	CYPRO-VITA	B	Vitamin C - 20mg, Vitamin B3 - 5mg, Vitamin B12 - 2.5mg, Vitamin B6 - 0.6mg, Vitamin B2 - 0.75mg, Vitamin B1 - 0.6mg, Vitamin D3 - 167IU, Vitamin A - 1670IU, Cyproheptadine HCl - 4mg		Tablet, film coated	409,552 L.L
B02BX01	DICYNONE	B	Etamsylate - 500mg	500mg	Capsule	1,311,590 L.L
B05DB	DIANEAL PD4 CYCLER 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l		Injectable solution	1,150,329 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	920,532 L.L
C10AA08	LIVAZO	B	Pitavastatin - 4mg	4mg	Tablet, film coated	1,835,305 L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 60mcg	60mcg	Tablet, Oral lyophilisate	2,484,765 L.L
M04AA01	ZYLORIC	B	Allopurinol - 300mg	300mg	Tablet	302,365 L.L
N05AX08	RISPERDAL	B	Risperidone - 4mg	4mg	Tablet	498,566 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 128mg	128mg	Injectable solution prolonged release	34,835,645 L.L
S02DA01	OTIPAX	B	Lidocaine HCl - 1g/100g, Phenazone - 4g/100g		Drops	236,516 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	L.L
A07EC02	ASACOL	B	Mesalazine - 1g/100ml	1g/100ml	Enema	2,748,158 L.L
A11BA	VITALIPID N INFANT	B	Vitamin A - 230IU/ml, Vitamin D2 - 40IU/ml, Vitamin E - 0.7IU/ml, Vitamin K1 - 20mcg/ml		Injectable concentrate for solution	2,448,481 L.L
B05DB	DIANEAL PD4 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l	1.36%	Injectable solution	1,163,270 L.L
N05AX08	RISPERDAL	B	Risperidone - 4mg	4mg	Tablet	498,566 L.L
S02DC	WAXSOL	B	Docusate sodium - 0.5%	0.5%	Drops solution	157,230 L.L
A07EC02	SALOFALK	B	Mesalazine - 1.5g	1.5g	Granules, gastro-resistant, prolonged release	6,150,767 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	2,218,684 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	79,847,895 L.L

National Cancer Registry (NCR)